TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8598837

Group type: EXPERIMENTAL
Intervention: Induction of labor with intravenous oxytocin
Number of subjects: 5041

Group type: EXPERIMENTAL
Intervention: Induction of labor with vaginal prostaglandin E2 gel
Number of subjects: 5041

Group type: COMPARATOR
Intervention: Expectant management (oxytocin)
Number of subjects: 5041

Group type: COMPARATOR
Intervention: Expectant management (prostaglandin)
Number of subjects: 5041
Study: 2058572

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (PUFAs)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control diet (without fish-oil supplement)
Number of subjects: 36
Study: 6337322

Group type: EXPERIMENTAL
Intervention: Decongestant-antihistamine combination (pseudoephedrine hydrochloride, 4 mg/kg/day and chlorpheniramine maleate, 0.35 mg/kg/day)
Number of subjects: 553

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Decongestant-antihistamine combination
Number of subjects: 553
Study: 31707107

Group type: EXPERIMENTAL
Intervention: Sensorimotor rhythm (SMR) NFB (n = 15)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Slow cortical potentials (SCP) NFB (n = 16)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham NFB (n = 13)
Number of subjects: 44
Study: 29886635

Group type: EXPERIMENTAL
Intervention: Simplified drilling method (guided drill + final drill)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional drilling method (step by step drill)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Simplified drilling method
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional drilling method
Number of subjects: 46
Study: 27411268

Group type: EXPERIMENTAL
Intervention: Tourniquet group
Number of subjects: 168

Group type: COMPARATOR
Intervention: Non-tourniquet group
Number of subjects: 168
Study: 24360612

Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional Care Regimens (CCR)
Number of subjects: 0
Study: 22842212

Group type: EXPERIMENTAL
Intervention: Single oral dose of citalopram
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 19800816

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 1765

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1765
Study: 18001404

Group type: EXPERIMENTAL
Intervention: 10-day moxifloxacin-based triple therapy (moxifloxacin 400 mg q.d., amoxicillin 1000 mg b.i.d., esomeprazole 20 mg b.i.d.)
Number of subjects: 192

Group type: COMPARATOR
Intervention: 2-week quadruple therapy (esomeprazole 20 mg b.i.d., tripotassium dicitrate bismuthate 300 mg q.i.d., metronidazole 500 mg t.i.d., tetracycline 500 mg q.i.d.)
Number of subjects: 192
Study: 15698450

Group type: EXPERIMENTAL
Intervention: CAPD with a target creatinine clearance >/=60 L/week/1.73 m(2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 4 x 2 L continuous ambulatory peritoneal dialysis (CAPD)
Number of subjects: 0
Study: 11960607

Group type: EXPERIMENTAL
Intervention: Complete antioxidant formula (alpha‐tocopherol, alpha‐lipoic acid, coenzyme Q(10), carnitines, selenomethionine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Incomplete antioxidant formula (alpha‐tocopherol, alpha‐lipoic acid, coenzyme Q(10), selenomethionine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Carnitines
Number of subjects: 20
Study: 9931813

Group type: EXPERIMENTAL
Intervention: Therapeutic splitting (ERC/EPT, followed by laparoscopic cholecystectomy)
Number of subjects: 3618
Study: 7653482

Group type: EXPERIMENTAL
Intervention: Intermittent cyclic etidronate (400 mg/d for 14 days followed by calcium 500 mg/d for 76 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Calcium supplementation (500 mg/d)
Number of subjects: 39
Study: 2510348

Group type: EXPERIMENTAL
Intervention: DDAVP (desamino‐d‐arginine vasopressin) intravenously
Number of subjects: 6
Study: 1232529

Group type: EXPERIMENTAL
Intervention: Melphalan and prednisone 0.6 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melphalan and prednisone 0.3 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Melphalan alone
Number of subjects: 0
Study: 31753043

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 151
Study: 30119088

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28946577

Group type: EXPERIMENTAL
Intervention: Task specific training and wrist/fingers extension splint
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional passive stretch and range of motion exercises
Number of subjects: 24
Study: 26063699

Group type: EXPERIMENTAL
Intervention: Triple P levels 2‐3
Number of subjects: 759

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 759
Study: 22897451

Group type: EXPERIMENTAL
Intervention: Baseline compensation use
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cognitive impairment (measured by RBANS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Family-reported memory problems (NFI)
Number of subjects: 22
Study: 20373478

Group type: EXPERIMENTAL
Intervention: 20 mg tandospirone (TSP)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 5 mg diazepam (DZP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PCB)
Number of subjects: 18
Study: 18307248

Group type: EXPERIMENTAL
Intervention: Alcoholic beverage
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 70
Study: 16536020

Group type: EXPERIMENTAL
Intervention: Non-Invasive Mechanical Ventilation (NIMV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxygen-therapy with helmet
Number of subjects: 0
Study: 12507212

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Controlled Clinical Trials (CCTs)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Reports of RCTs registered in Medline
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Hand-searching
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Literature search in Medline
Number of subjects: 210
Study: 10520446

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 2
Study: 7729275

Group type: EXPERIMENTAL
Intervention: Misoprostol coadministered with diclofenac
Number of subjects: 384

Group type: COMPARATOR
Intervention: Placebo coadministered with diclofenac
Number of subjects: 384
Study: 2325568

Group type: EXPERIMENTAL
Intervention: 1,25‐(OH)2D3 (calcitriol; Rocaltrol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study: 7024157

Group type: EXPERIMENTAL
Intervention: Very-low-calorie diet with exercise (1650 kcal/week, 3 times a week)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Very-low-calorie diet alone
Number of subjects: 18
Study: 30181533

Group type: EXPERIMENTAL
Intervention: EBD combined with triamcinolone (50 mg/5 mL)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 65
Study: 26497691

Group type: EXPERIMENTAL
Intervention: Nicotine cigarettes (8.9 mg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo cigarettes (1.0 mg)
Number of subjects: 96
Study: 24835579

Group type: EXPERIMENTAL
Intervention: Twin intervention (TI) group
Number of subjects: 162

Group type: COMPARATOR
Intervention: Twin control (TC) group
Number of subjects: 162
Study: 22348801

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard distraction
Number of subjects: 41
Study: 21112427

Group type: EXPERIMENTAL
Intervention: Anterior AFO
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Posterior AFO
Number of subjects: 14

Group type: COMPARATOR
Intervention: No AFO
Number of subjects: 14
Study: 18772208

Group type: EXPERIMENTAL
Intervention: Case conferences between GPs and specialist palliative care services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care and communication methods
Number of subjects: 0
Study: 15871316

Group type: EXPERIMENTAL
Intervention: 10 U botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 20 U botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 30 U botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 40 U botulinum toxin type A
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 30 U botulinum toxin type A (open-label extension)
Number of subjects: 80
Study: 12799115

Group type: EXPERIMENTAL
Intervention: Listerine (pH 3.87, F(-) 0.021 ppm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Corsodyl (pH 5.65, F(-) 0 ppm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tesco Value (pH 6.05, F(-) 289.00 ppm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tesco Total Care (pH 6.20, F(-) 313.84 ppm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sainsbury's (pH 6.15, F(-) 365.75 ppm)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sensodyne (pH 6.12, F(-) 285.30 ppm)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Positive control (citric acid, pH 2.7, F(-) 0 ppm)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Negative control (pH 7.0, F(-) 0 ppm)
Number of subjects: 48
Study: 10470633

Group type: EXPERIMENTAL
Intervention: Tramadol (150 mg bolus + 250 mg infusion over 3 hours)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Meperidine (112.5 mg bolus + 187.5 mg infusion over 3 hours)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 8
Study: 8609263

Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 323

Group type: COMPARATOR
Intervention: Tretinoin gel 0.025%
Number of subjects: 323
Study: 1936478

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 60
Study: 7035441

Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 43

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 43
Study: 30701467

Group type: EXPERIMENTAL
Intervention: 50 mg thalidomide maintenance (Group B)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 100 mg thalidomide maintenance (Group C)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No maintenance (Group A)
Number of subjects: 34
Study: 28681218

Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2, day 1) with paclitaxel (80 mg/m2, days 1, 8, and 15) every 21 days as neoadjuvant chemotherapy (NAC) for 3 cycles before radical hysterectomy (RH).
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cisplatin plus dose-dense paclitaxel (dose-dense TP) for 3 cycles before and 2 cycles after radical hysterectomy (RH).
Number of subjects: 63
Study: 26920745

Group type: EXPERIMENTAL
Intervention: Workplace mental health intervention (multi-session leadership coaching and tailored mental health literacy training)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Workplace mental health intervention
Number of subjects: 240
Study: 24720402

Group type: EXPERIMENTAL
Intervention: Bixalomer (1.5 g/day adjusted to a maximum of 7.5 g/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Sevelamer hydrochloride (3.0 or 6.0 g/day adjusted to a maximum of 9.0 g/day)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Bixalomer
Number of subjects: 110
Study: 22929118

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation for twelve weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corn oil supplementation for twelve weeks
Number of subjects: 0
Study: 18945653

Group type: EXPERIMENTAL
Intervention: Half elemental diet (ED)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Free diet
Number of subjects: 51
Study: 17200765

Group type: EXPERIMENTAL
Intervention: EE‐EC (estrogen and levonorgestrel)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: LNG‐EC (levonorgestrel only)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 11
Study: 16083710

Group type: COMPARATOR
Intervention: lamivudine 100 mg/day
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: telbivudine 400 mg/day
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: telbivudine 600 mg/day
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Comb400 (telbivudine 400 mg/day + lamivudine 100 mg/day)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Comb600 (telbivudine 600 mg/day + lamivudine 100 mg/day)
Number of subjects: 104
Study: 12569811

Group type: EXPERIMENTAL
Intervention: Decalcified dental matrix (DDM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no DDM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 42
Study: 10721440

Group type: EXPERIMENTAL
Intervention: Self-management intervention (n = 44)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Wait-list control (n = 48)
Number of subjects: 92
Study: 7993000

Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/d)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 1701924

Group type: EXPERIMENTAL
Intervention: m-BACOD (doxorubicin-containing regimen)
Number of subjects: 70

Group type: COMPARATOR
Intervention: m-BNCOD (mitoxantrone-containing regimen)
Number of subjects: 70
Study: 7011293

Group type: EXPERIMENTAL
Intervention: Two tablets (0.96 grams) of Co-trimoxazole twice a day for one day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Four tablets (1.92 grams) of Co-trimoxazole as a single dose
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Two tablets of Co-trimoxazole twice a day for seven days
Number of subjects: 48
Study: 30334934

Group type: EXPERIMENTAL
Intervention: Regional Anesthesia (RA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 100
Study: 31747035

Group type: EXPERIMENTAL
Intervention: Positive valence system-focused cognitive behavioral therapy with inaudible high-frequency sound
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy with placebo sound
Number of subjects: 44
Study: 28062916

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg ATG
Number of subjects: 38

Group type: COMPARATOR
Intervention: No ATG (reference arm)
Number of subjects: 38
Study: 26264417

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: Acute smoking
Number of subjects: 21

Group type: COMPARATOR
Intervention: Exercise followed by smoking
Number of subjects: 21

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonsmokers during exercise
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Smokers during exercise
Number of subjects: 21
Study: 23399350

Group type: EXPERIMENTAL
Intervention: Hypertensive pregnancy disorders (HTP)
Number of subjects: 405
Study: 22524073

Group type: EXPERIMENTAL
Intervention: Zinc Oxide Eugenol (ZOE)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Zinc Polycarboxylate (ZPC)
Number of subjects: 120
Study: 20449933

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 84
Study: 18001454

Group type: EXPERIMENTAL
Intervention: Endoloop
Number of subjects: 102
Study: 15033248

Group type: EXPERIMENTAL
Intervention: Ischaemic rest pain (IRP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Intermittent claudication (IC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Acute myocardial infarction (AMI)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study: 11244376

Group type: EXPERIMENTAL
Intervention: Serotonin reuptake inhibitors (SRIs)
Number of subjects: 93
Study: 9738752

Group type: EXPERIMENTAL
Intervention: Preoperative intravenous antibiotics followed by oral antibiotics for 5 days after surgery
Number of subjects: 146

Group type: COMPARATOR
Intervention: No prophylactic antibiotics (control group)
Number of subjects: 146
Study: 11271328

Group type: EXPERIMENTAL
Intervention: FK 506
Number of subjects: 17

Group type: COMPARATOR
Intervention: cyclosporin A
Number of subjects: 17
Study: 2470995

Group type: EXPERIMENTAL
Intervention: Isradipine 15 mg/day
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Isradipine (various doses: 0, 2.5, 5, 7.5, or 10 mg twice daily)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 203
Study: 15725154

Group type: EXPERIMENTAL
Intervention: Obese individuals (Group I)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Overweight individuals (Group II)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Normal BMI individuals (Group III)
Number of subjects: 122
Study: 31667490

Group type: EXPERIMENTAL
Intervention: Cash transfer conditional on school attendance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parental monitoring and involvement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reporting a partner would hit her if she asked him to wear a condom
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All mediators jointly
Number of subjects: 0
Study: 31185118

Group type: EXPERIMENTAL
Intervention: Midline lumbar fusion (MidLIF) with cortical bone trajectory (CBT) screw fixation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Transforaminal lumbar interbody fusion (TLIF) using traditional pedicle screw (TPS) fixation
Number of subjects: 70
Study: 29217019

Group type: EXPERIMENTAL
Intervention: Mozart music (sonata for 2 pianos in D-K448)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Silence (control group)
Number of subjects: 26
Study: 26300367

Group type: EXPERIMENTAL
Intervention: Smoking hygiene intervention delivered by trained community health workers
Number of subjects: 318

Group type: COMPARATOR
Intervention: Control group (comparison group)
Number of subjects: 318
Study: 23316787

Group type: EXPERIMENTAL
Intervention: Coaching
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Learning sessions
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Combination of all three components
Number of subjects: 201

Group type: COMPARATOR
Intervention: Interest circle calls
Number of subjects: 201
Study: 23548251

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 μg per vaginally at 24 hours after mifepristone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mifepristone and misoprostol combination at 48 hours interval
Number of subjects: 200
Study: 19488583

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 42

Group type: COMPARATOR
Intervention: General anesthesia (control)
Number of subjects: 42
Study: 16796988

Group type: EXPERIMENTAL
Intervention: Suture approximation of Camper's fascia
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Closed suction drainage of the subcutaneous space
Number of subjects: 222

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 222
Study: 12616322

Group type: EXPERIMENTAL
Intervention: (18)FDG-PET
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combined (18)FDG-PET and BS
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: SPET LS images
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Combined analysis of planar BS and LS
Number of subjects: 17
Study: 10661480

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg daily with or without betaine 4 g per day for 12 weeks, followed by 1 or 5 mg of folic acid thereafter for 40 weeks.
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Folic acid treatment for hyperhomocysteinemia.
Number of subjects: 54
Study: 9288665

Group type: EXPERIMENTAL
Intervention: Surfactant administration
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control (PRE phase)
Number of subjects: 348
Study: 7682932

Group type: EXPERIMENTAL
Intervention: 24 h free-field exposure to intermittent trains of 89 dB low frequency tones
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: tones presented through headphones
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: target-induced ERSPs
Number of subjects: 28
Study: 3552397

Group type: EXPERIMENTAL
Intervention: Fibre optic transillumination (FOTI)
Number of subjects: 3003
Study: 31424631

Group type: EXPERIMENTAL
Intervention: Single-arm trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0
Study: 29465059

Group type: EXPERIMENTAL
Intervention: Glutaraldehyde-containing agent (GCA) application
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser (1 W/cm2, 10 Hz) irradiation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GCA application followed by Nd:YAG laser irradiation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (0.25 W/cm2, 20 Hz) irradiation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GCA application followed by Er,Cr:YSGG laser irradiation
Number of subjects: 17
Study: 27764692

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 76
Study: 25354985

Group type: EXPERIMENTAL
Intervention: Hand hygiene education and individual feedback
Number of subjects: 24
Study: 24074810

Group type: EXPERIMENTAL
Intervention: Ketoconazole (KTCZ) with low-dose cortisol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketoconazole (KTCZ) with high-dose cortisol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study: 21959825

Group type: EXPERIMENTAL
Intervention: Thiazide + Losartan 50 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Thiazide 50 mg/day
Number of subjects: 60
Study: 18245696

Group type: EXPERIMENTAL
Intervention: Tubing containing diethylhexyl phthalate (Group A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Tubing without diethylhexyl phthalate (Group B)
Number of subjects: 16
Study: 16841795

Group type: EXPERIMENTAL
Intervention: Imatinib mesylate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyurea and busulfan
Number of subjects: 0
Study: 12638027

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/d for 3 months
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 54
Study: 10638876

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control (Social Work)
Number of subjects: 135